Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies
Open Access

Patient’s HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma

RIINA K. OLLIKAINEN, ANTTI SIPPOLA, TAINA TURPEENNIEMI-HUJANEN, HANNE KUITUNEN, KATJA PORVARI, KIRSI-MARIA HAAPASAARI, MILLA E.L. KUUSISTO, TUULA KLAAVUNIEMI and OUTI KUITTINEN
Anticancer Research August 2024, 44 (8) 3255-3259; DOI: https://doi.org/10.21873/anticanres.17143
RIINA K. OLLIKAINEN
1Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland;
2Cancer Center, Oulu University Hospital, Oulu, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: riinolli{at}uef.fi
ANTTI SIPPOLA
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAINA TURPEENNIEMI-HUJANEN
2Cancer Center, Oulu University Hospital, Oulu, Finland;
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HANNE KUITUNEN
2Cancer Center, Oulu University Hospital, Oulu, Finland;
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KATJA PORVARI
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KIRSI-MARIA HAAPASAARI
4Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MILLA E.L. KUUSISTO
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
5Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland;
6Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TUULA KLAAVUNIEMI
1Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OUTI KUITTINEN
1Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland;
3Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
7Cancer Center, Kuopio University Hospital, Kuopio, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

Anticancer Research: 44 (8)
Anticancer Research
Vol. 44, Issue 8
August 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patient’s HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 15 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Patient’s HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma
RIINA K. OLLIKAINEN, ANTTI SIPPOLA, TAINA TURPEENNIEMI-HUJANEN, HANNE KUITUNEN, KATJA PORVARI, KIRSI-MARIA HAAPASAARI, MILLA E.L. KUUSISTO, TUULA KLAAVUNIEMI, OUTI KUITTINEN
Anticancer Research Aug 2024, 44 (8) 3255-3259; DOI: 10.21873/anticanres.17143

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Patient’s HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma
RIINA K. OLLIKAINEN, ANTTI SIPPOLA, TAINA TURPEENNIEMI-HUJANEN, HANNE KUITUNEN, KATJA PORVARI, KIRSI-MARIA HAAPASAARI, MILLA E.L. KUUSISTO, TUULA KLAAVUNIEMI, OUTI KUITTINEN
Anticancer Research Aug 2024, 44 (8) 3255-3259; DOI: 10.21873/anticanres.17143
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 6-O-Carboxypropyl-α-Tocotrienol Enhances the Anticancer Effects of Bortezomib Without Suppressing NRF1 and NRF3 in Colorectal Cancer Cells
  • Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer
  • Imipramine Targets Apoptosis, Metastasis, and EGFR/SRC-mediated EMT in Oral Cancer Cells
Show more Experimental Studies

Keywords

  • HLA-A*31
  • B-cell lymphoma
  • CNS disease
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire